ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #153Top JournalHybrid

Cancer Discovery

Abbreviation (ISO):CANCER DISCOV
•
Identifier (ISSN):2159-8274(Print)/2159-8290(Online)
•
Publisher:American Association for Cancer Research Inc.
Clarivate IF (2026)
29.5↓ -3.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Discovery

WoS Q1
1728395124.4201826.4201929.5202039.4202138.3202228.2202329.7202433.3202529.52026
Annual Impact Factor Metric
Current (2026):29.5
Scopus SJR & RankScopus Q1
7.389
#153

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
265

265 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
181articles/year
51.29% Gold OA•88.97% Original Research

Aims & Scope

Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. As the premier cancer information resource, the Journal also presents Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of important journal articles to its readers to keep them informed about the latest findings in the field. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic and epidemiologic studies

Topics Covered (Recognized by AI)
Biology91%Medicine77.1%Genetics75.1%Internal medicine61.3%Chemistry59.3%Cancer research56.2%Biochemistry55.5%Computational biology51.5%Cancer46.2%Gene37.2%Cell biology27.5%Immunology26%Pathology21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank10/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank8/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF29.5
Articles / Year325
Total Citations189
2025
IF33.3
Articles / Year400
Total Citations1,945
2024
IF29.7
Articles / Year486
Total Citations7,133
2023
IF28.2
Articles / Year507
Total Citations9,328
2022
IF38.272
Articles / Year532
Total Citations24,024

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #153Scopus Q1SCImago Profile
Scopus Coverage:2011-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
7.389

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
11.31

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,780 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,992
3-Year Documents1,050
Citable Documents965

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Discovery (abbr: CANCER DISCOV, ISSN: 2159-8274) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by American Association for Cancer Research Inc. in United States since 2011. The periodical holds a Journal Impact Factor (JIF) of 29.5, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 7.389 (Q1), an H-index of 265.

The journal enforces rigorous peer evaluation with an annual output of approximately 181 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,780 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Periodic
Founding Year
2011
Indexing & Databases
SCIEScopusPubMed
Editorial Address
615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f223025c-7bef-4ef3-9f8b-e5f85ac32e00
Database Updated: 2026-10-01